Paper: Governments' and Physicians' Opposing Views on Rx Value Could Complicate Patient Care
Differing approaches to medication value may undermine patient-centered care as the Inflation Reduction Act allows officials to negotiate some Medicare Rx prices
WASHINGTON, Aug. 30, 2023 /PRNewswire/ -- Government officials and physicians don't always agree on the value of prescription drugs, a new paper from the Alliance for Patient Access explains, and the discrepancy could impact patient care when U.S. officials begin price negotiations for certain Medicare drugs as authorized by the Inflation Reduction Act.
About the Research
To examine discrepancies in medication value, researchers asked 350 U.S. physicians to respond to a European government's assessments of certain drugs for three conditions: ulcerative colitis, psoriatic arthritis and multiple myeloma.
The research used metrics from Germany's Federal Joint Committee, or G-BA, the centralized decision-making body in Germany's health care system.
Key Findings
Only 10% of U.S. physicians agreed with the G-BA's negative assessments of the innovative medications. And the overwhelming majority ? 90% ? said the medications had additional benefits for patients.
The gap suggests that physicians and government agents approach the question of value differently, the paper explains. Physicians are likely to also consider real-world factors such as:
Unmet needs
A medication's ability to prolong life expectancy until the next treatment is available
The method and frequency of drug administration
Indirect benefits, such as allowing patients or caregivers to continue working
The research echoes similar findings from 2019, when 89% of surveyed U.S. physicians disagreed with the G-BA's negative evaluation of innovative diabetes medications and 97% said the medications offered additional value for patients.
Physicians consider the nuances of their patient's diagnosis, comorbidities, health history and lifestyle, the paper notes. Government agents take a more systemwide, population-health approach.
Implications for Patient Care
Establishing drug prices based solely on a government definition of value could create challenges for patients, such as:
Inability to access new treatment if insurance plans make certain drugs harder to access.
Less personalized care as physicians feel compelled to make treatment decisions based primarily on cost.
More frequent non-medical switching, where health plans drive stable patients from effective treatment to a more profitable alternative, triggering side effects and re-emerging symptoms.
Less research and medical innovation, with experts predicting that 135 fewer new drugs will come to market over the next two decades.
Andreozzi + Foote, representing Plaintiff J.C., has filed a lawsuit against Pain Relief Chiropractic, P.C. and Stina's Herbcraft and Massage Therapy. The lawsuit alleges negligence, gross negligence, carelessness, and recklessness on the part of the...
EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and...
Maplewood Senior Living, a leading national provider of senior living residences with 16 communities across the Northeast and Ohio, is honored to host Teepa Snow, the acclaimed occupational therapist, leading educator, and dementia care expert, for a...
Novobeing, a pioneer in immersive technology for enhanced well-being, is proud to announce its selection in the Roux Institute at Northeastern University's Future of Healthcare Founder Residency program....
Shaw Industries Group, Inc. (Shaw) has been recognized by ComPsych® Corporation ? the world's largest provider of mental health services - as one of the winners of the 2023 Health at Work Awards. Shaw won the silver category for the Large Group...
Perspecta, the leading provider of provider directories and provider data management for workers' compensation, government, and healthcare, proudly unveils its latest innovation: My Workers' Compensation ID (My WC ID), a mobile app that serves as a...